Extracts
Device Can Analyze Genes At Patients' Bedside
Knowing the genomic signature of a cell population can help doctors diagnose diseases and may allow them to predict how individual patients will respond to trauma and what treatments to order.
University of Florida researchers have helped to develop a device that quickly identifies genes and proteins in body fluids — a technique that could make a vital difference to the patients doctors treat.
In a study published in a recent issue of Nature Medicine, scientists describe how they developed and tested a new way to isolate cells from patient samples and analyze them to help predict outcomes after severe trauma. The technology, called a microfluidic cassette, allows precise analysis of very small volumes of fluids and can be used to study patients’ genes and proteins.
“Theoretically, you can isolate any cell population, under any disease, and rapidly get nucleic acids to produce a genomic signature,” said Lyle L. Moldawer, a professor and vice chairman of research in the UF College of Medicine’s Department of Surgery.
The approach also could be used with patients who have cancer or other conditions.
Moldawer, a co-author of the paper who also directs the department’s Laboratory of Inflammation Biology and Surgical Science, said the team that developed and tested the cassette did so to isolate neutrophils, the first type of white blood cell on the scene of an infection, and to analyze the proteins they produce. These proteins indicate how genes that regulate the immune system respond to trauma, which may allow health-care providers to quickly identify patients more likely to develop serious complications.
The device was constructed by a team at Massachusetts General Hospital and sent to UF for initial testing, spearheaded by Elizabeth Warner, a surgical resident researcher and a co-author of the paper. Scientists from several other institutions, including Stanford University, the University of Rochester, the University of Washington, Pacific Northwest National Laboratory, Harvard University and Washington University in St. Louis also co-authored the paper.
“We’ve identified 63 genes that are differentially expressed,” Moldawer said, “so that when you are admitted to the emergency room after severe trauma, we can hopefully tell with better certainty whether you’re going to have a good or bad outcome (by looking at these genes).”
The genes in question regulate functions of the immune system. Patients whose expression of these genes is abnormal, he said, are less likely to return to their normal immune function within days of trauma, as most patients do. This leaves them more vulnerable to infections and a myriad of related complications.
Previous devices required 4 to 8 milliliters of fluids, the work of a highly skilled technician and several hours to complete analysis.
Kenneth Kotz, a research fellow in the department of surgery at Massachusetts General Hospital, built the device, which is laced with antibodies that capture the individual cells when a sample of fluid, such as blood or urine, is pumped through it. Nucleic acids or proteins from the cells are then extracted from the cassette, allowing researchers to analyze how specific genes are expressed.
Testing showed the device yielded pure samples of neutrophils, and their gene expression pattern was consistent with results from tests performed in earlier studies.
Lyle Moldawer, moldawer@surgery.ufl.edu